Some 13 million Americans struggle with post-traumatic stress disorder (PTSD). Existing therapies only bring relief for a fraction of patients, and new treatments are sorely needed, according to psychiatrists wrestling with the scale of the problem. So, there was distinct disappointment when an advisory committee at the US Food and Drug Administration (FDA) voted earlier this month against a therapy that many had hoped could offer the first new treatment for PTSD in 25 years.

A number of experts who study psychedelics have since spoken out in support of MDMA-assisted therapy for PTSD and have sharply criticised the recommendations of the FDA’s Psychopharmacological Drugs Advisory Committee. But some are still optimistic that the treatment might be approved when the FDA delivers its final decision in August.

Ahead of the meeting, FDA approval of MDMA-assisted therapy for PTSD seemed likely, says Sandeep Nayak, an assistant professor of psychiatry at Johns Hopkins University, who investigates psychedelics as treatments for substance use and mood disorders. About two-thirds of people who received three sessions of MDMA and talk therapy no longer qualified for a PTSD diagnosis at the end of two Phase 3 clinical trials.

It’s an outcome that is “almost double that of existing medications”, says Gül Dölen, a neuroscientist at the University of California, Berkeley, who researches the mechanisms of how psychedelics achieve therapeutic effects. “What’s more, [the treatment] led to durable improvements in these patients lasting at least six months.”

  • treefrog@lemm.ee
    link
    fedilink
    arrow-up
    18
    arrow-down
    2
    ·
    5 months ago

    I would love to know how many members of this board have stock portfolios in pharmaceutical companies that are currently collecting huge amounts of money from antidepressants being used to treat people with PTSD.

    Antidepressants that really aren’t effective in the treatment of PTSD but make the pharmaceutical industry a shitload of money.

    Like most things, when we follow the money we learn why powerful people make the decisions they do. And I imagine this instance is no different.